
Natalie Kamberos DO
Pediatric Coagulation Disorder Hematology
Associate
Join to View Full Profile
2160 S. First Ave.Ste. 3303Maywood, IL 60153
Phone+1 708-327-9095
Dr. Kamberos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, 2009 - 2012
- UnityPoint Health-Iowa Lutheran HospitalResidency, 2006 - 2009
- University of Iowa Hospitals and ClinicsResidency, 2006 - 2009
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2006
Certifications & Licensure
- IA State License 2007 - 2026
- IL State License 2015 - 2026
- MO State License 2021 - 2026
- WI State License 2023 - 2025
- DC State License 2017 - 2020
- WV State License 2015 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 25 citationsEffect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.James F. Casella, Bruce A. Barton, Julie Kanter, L. Vandy Black, Suvankar Majumdar
JAMA. 2021-04-20 - 12 citationsCDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myelomaSeong-Su Han, Van S. Tompkins, Dong Ju Son, Sangwoo Han, Hwakyung Yun
Experimental Hematology & Oncology. 2015-03-27 - 21 citationsPiperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.Seong-Su Han, Sangwoo Han, Natalie L. Kamberos
Biochemical and Biophysical Research Communications. 2014-09-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: